About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Observational Study to Evaluate the Safety of Levemir® in Diabetes

Observational Study to Evaluate the Safety of Levemir® in Diabetes

NCT00706017·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Novo Nordisk A/S

Age

Any age

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Type 1 or 2 diabetes
Including newly diagnosed not on insulin or insulin analogue treatment
Selection at the discretion of the physician
Adult patients with type 1 and 2 diabetes mellitus, and type 1 patients 6 years and older

You may not be if

Current treatment with Levemir®
Previously enrolled in the study
Hypersensitivity to Levemir®

The record

StatusCompleted

PhaseNo phase

Taking part2,282

StartedSep 2007

UpdatedOct 28, 2016

Conditions

Diabetes Diabetes Mellitus, Type 1 Diabetes Mellitus, Type 2

Where1

Novo Nordisk Investigational Site
Mexico City, Mexico